Quarterly report · Q3
6063.TEDINET S100PL8K
Period2022-01-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥4.4bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥619m | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥181m | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥649m | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥244m | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥190m | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥648m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥196m | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥448m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥179m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥136m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥448m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥136m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥4.0bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥3.8bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.4bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.7bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥177.82 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.55 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.92 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.53 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥177.79 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥70.96 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥53.89 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 39.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.3% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥268m |
| jpcrp040300-q3r_E26625-000Life Assistancereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥321m |
| jpcrp040300-q3r_E26625-000Life Assistancereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥321m |
| jpcrp040300-q3r_E26625-000Life Assistancereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥167m |
| jpcrp040300-q3r_E26625-000Medical Assistancereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q3r_E26625-000Medical Assistancereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q3r_E26625-000Medical Assistancereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥719m |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥4.7bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥4.7bn |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥887m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | −¥236m |
| jpcrp040300-q3r_E26625-000Life Assistancereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥394m |
| jpcrp040300-q3r_E26625-000Life Assistancereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥394m |
| jpcrp040300-q3r_E26625-000Life Assistancereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥246m |
| jpcrp040300-q3r_E26625-000Medical Assistancereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.5bn |
| jpcrp040300-q3r_E26625-000Medical Assistancereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.5bn |
| jpcrp040300-q3r_E26625-000Medical Assistancereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥171m |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥2.9bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥2.9bn |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥417m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 311
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |